McDonald; Joseph John
Patent Applications and Registrations
Patent applications and USPTO patent grants for McDonald; Joseph John.The latest application filed is for "mk2 inhibitors and uses thereof".
- McDonald; Joseph John - Sudbury MA
| Patent | Date |
|---|---|
| MK2 inhibitors and uses thereof Grant 11,098,061 - Alexander , et al. August 24, 2 | 2021-08-24 |
| Mk2 Inhibitors And Uses Thereof App 20210053984 - Alexander; Matthew David ; et al. | 2021-02-25 |
| Heteroaryl compounds and uses thereof Grant 10,774,052 - D'Agostino , et al. September 15, 2 | 2020-09-15 |
| Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,618,902 - D'Agostino , et al. | 2020-04-14 |
| MK2 inhibitors and uses thereof Grant 10,577,380 - Alexander , et al. | 2020-03-03 |
| Heteroaryl Compounds And Uses Thereof App 20190375719 - D'Agostino; Laura Akullian ; et al. | 2019-12-12 |
| Mk2 Inhibitors And Uses Thereof App 20190375762 - Alexander; Matthew David ; et al. | 2019-12-12 |
| Heteroaryl Compounds And Uses Thereof App 20190218220 - D'Agostino; Laura Akullian ; et al. | 2019-07-18 |
| Mk2 Inhibitors And Uses Thereof App 20190135835 - Alexander; Matthew David ; et al. | 2019-05-09 |
| MK2 inhibitors and uses thereof Grant 10,253,040 - Alexander , et al. | 2019-04-09 |
| Heteroaryl compounds and uses thereof Grant 10,189,794 - D'Agostino , et al. Ja | 2019-01-29 |
| MK2 inhibitors and uses thereof Grant 10,138,256 - Alexander , et al. Nov | 2018-11-27 |
| Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,065,966 - D'Agostino , et al. September 4, 2 | 2018-09-04 |
| Heteroaryl Compounds And Uses Thereof App 20180022713 - D'Agostino; Laura Akullian ; et al. | 2018-01-25 |
| MK2 inhibitors and uses thereof Grant 9,790,235 - Alexander , et al. October 17, 2 | 2017-10-17 |
| Heteroaryl Compounds And Uses Thereof App 20170267685 - D'Agostino; Laura Akullian ; et al. | 2017-09-21 |
| Heteroaryl compounds and uses thereof Grant 9,695,132 - D'Agostino , et al. July 4, 2 | 2017-07-04 |
| Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors Grant 9,663,524 - D'Agostino , et al. May 30, 2 | 2017-05-30 |
| Mk2 Inhibitors And Uses Thereof App 20170114073 - Alexander; Matthew David ; et al. | 2017-04-27 |
| MK2 inhibitors and uses thereof Grant 9,458,175 - Alexander , et al. October 4, 2 | 2016-10-04 |
| Heteroaryl Compounds And Uses Thereof App 20160221966 - D'Agostino; Laura Akullian ; et al. | 2016-08-04 |
| Heteroaryl compounds and uses thereof Grant 9,321,786 - D'Agostino , et al. April 26, 2 | 2016-04-26 |
| Mk2 Inhibitors And Uses Thereof App 20160075720 - Alexander; Matthew David ; et al. | 2016-03-17 |
| Heteroaryl Compounds And Uses Thereof App 20160046634 - D'Agostino; Laura Akullian ; et al. | 2016-02-18 |
| Mk2 Inhibitors And Uses Thereof App 20150376208 - ALEXANDER; Matthew David ; et al. | 2015-12-31 |
| Heteroaryl Compounds And Uses Thereof App 20140296233 - D'Agostino; Laura Akullian ; et al. | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 